Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
Maurizio Benucci,1 Arianna Damiani,1 Mariangela Manfredi,2 Maria Infantino,2 Valentina Grossi,2 Francesca Li Gobbi11Rheumatology Unit, S.Giovanni di Dio Hospital, Florence, Italy; 2Immunology and Allergology Laboratory Unit, S.Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, ItalyAbst...
Saved in:
Main Authors: | Benucci M (Author), Damiani A (Author), Manfredi M (Author), Infantino M (Author), Grossi V (Author), Li Gobbi F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
by: Benucci M, et al.
Published: (2018) -
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
by: Benucci M, et al.
Published: (2020) -
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
by: Benucci M, et al.
Published: (2017) -
Jaccoud's arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment
by: M. Benucci, et al.
Published: (2017) -
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
by: M. Benucci, et al.
Published: (2016)